Beijing Science Sun Pharmaceutical Co Ltd (300485) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.68 Million ≈ $4.20 Million USD) by net assets (CN¥3.43 Billion ≈ $502.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300485 equity to assets ratio to measure how much of total assets are equity-financed.

Beijing Science Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300485 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Beijing Science Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangdong Mingzhu Group Co Ltd SHG:600382	0.035x
Gansu Yatai Industrial Development Co Ltd SHE:000691	-0.880x
Arvind Fashions Limited NSE:ARVINDFASN	0.103x
Zhejiang JW Precision Machinery Co.Ltd SHE:300984	0.004x
Patrizia AG XETRA:PAT	0.038x
Guangdong Enpack Packaging Co Ltd SHE:002846	0.039x
Mama's Creations Inc. NASDAQ:MAMA	0.054x
Ta Ann Holdings Bhd KLSE:5012	0.041x

Annual Cash Flow Conversion Efficiency for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Beijing Science Sun Pharmaceutical Co Lt market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.39 Billion ≈ $495.39 Million	CN¥135.97 Million ≈ $19.90 Million	0.040x	+556.62%
2023-12-31	CN¥3.47 Billion ≈ $507.42 Million	CN¥21.21 Million ≈ $3.10 Million	0.006x	-81.10%
2022-12-31	CN¥3.41 Billion ≈ $499.28 Million	CN¥110.43 Million ≈ $16.16 Million	0.032x	-42.03%
2021-12-31	CN¥3.28 Billion ≈ $480.42 Million	CN¥183.30 Million ≈ $26.82 Million	0.056x	-39.67%
2020-12-31	CN¥2.85 Billion ≈ $417.03 Million	CN¥263.73 Million ≈ $38.59 Million	0.093x	+45.43%
2019-12-31	CN¥2.71 Billion ≈ $396.74 Million	CN¥172.52 Million ≈ $25.25 Million	0.064x	+10.99%
2018-12-31	CN¥2.56 Billion ≈ $373.95 Million	CN¥146.52 Million ≈ $21.44 Million	0.057x	+22.89%
2017-12-31	CN¥2.32 Billion ≈ $339.41 Million	CN¥108.21 Million ≈ $15.83 Million	0.047x	-54.03%
2016-12-31	CN¥2.10 Billion ≈ $307.00 Million	CN¥212.89 Million ≈ $31.15 Million	0.101x	+12.82%
2015-12-31	CN¥1.88 Billion ≈ $275.51 Million	CN¥169.36 Million ≈ $24.78 Million	0.090x	-72.85%
2014-12-31	CN¥646.64 Million ≈ $94.62 Million	CN¥214.23 Million ≈ $31.35 Million	0.331x	-16.90%
2013-12-31	CN¥493.71 Million ≈ $72.25 Million	CN¥196.82 Million ≈ $28.80 Million	0.399x	-5.55%
2012-12-31	CN¥359.96 Million ≈ $52.67 Million	CN¥151.93 Million ≈ $22.23 Million	0.422x	+35.50%
2011-12-31	CN¥247.37 Million ≈ $36.20 Million	CN¥77.06 Million ≈ $11.28 Million	0.312x	--

About Beijing Science Sun Pharmaceutical Co Ltd

SHE:300485 China Drug Manufacturers - Specialty & Generic

Market Cap

$644.21 Million

CN¥4.40 Billion CNY

Market Cap Rank

#10910 Global

#2971 in China

Share Price

CN¥9.14

Change (1 day)

+2.70%

52-Week Range

CN¥8.15 - CN¥15.18

All Time High

CN¥40.48